ERBB2 and breast carcinoma: The individual with a homozygous p.(Gln90Ter) variant had bilateral breast cancer at age 47 (grade 2, invasive lobular carcinoma, ER+, PR+, HER2−) and 53 (grade 2, invasive ductal carcinoma, ER+, PR+, HER2−).